Deal Architecture and Value Creation

• Sourced and advanced an under-indexed, de-risked asset mis-staged in global databases and therefore invisible to others; asset is positioned to become Standard of Care, extending company IP runway by 6+ years with near-term revenue accretion.
• Negotiated a Japan rare disease partnership, bridging divergent regulatory and commercial frameworks; uplifted milestones 45% and secured tiered double-digit royalties with tail.
• Identified and secured a de-risked Phase III asset that became the company's lead product, successfully launched four years later.
• Structured portfolio valuations and business case enabling a $10M private placement and a successful spinout.
• Presented company to Wall Street as one of three C-suite executives, securing a $6M private placement with a $2M follow-on.

Growth Strategy and New Venture Creation

• Modeled a new life sciences service repurposing medical records to identify rare disease patients earlier and connect them with relevant clinical trials; supported a 35% valuation uplift and a $275M PE acquisition.
• Evaluated joint venture and adjacent-market opportunities for a Fortune 500 utility navigating industry deregulation, advising on entry into telecommunications and other sectors.
• Built a multi-company business from a single product line into four distinct revenue streams, adding a consulting arm and developing expertise in product positioning, niche marketing, and media relations.
• Built a pipeline of near-term, synergistic follow-on opportunities supporting sustained growth optionality.

Enterprise Value and Portfolio Optimization

• Designed a predictive valuation model that ranked and prioritized 300+ pipeline assets, improving R&D resource allocation and increasing annual FDA submissions from 5 to 14.
• Led a Fortune 500 company's transition from EPS targets to cash-based value measures across seven business units, improving shareholder value alignment by approximately 30%.
• Partnered with Boston Consulting Group to drive portfolio-wide value management strategy; mentored senior executives and trained analysts on value creation frameworks.